Browse by Sector

Explore NASDAQ stocks by their primary economic sector.

All NASDAQ Stocks Healthcare 225 Information Technology 205 Industrials 84 Consumer Discretionary 60 Financials 53 Communication Services 32 Materials 28 Consumer Staples 12 Energy 9 Real Estate 1 Utilities 1

Industries in Healthcare

Refine the list using the company’s more specific operating industry.

Biotechnology 135 Healthcare Equipment & Supplies 30 Pharmaceuticals 28 Life Sciences Tools & Services 18 Healthcare Providers & Services 8 Health Care Technology 6
Curated industry list

High-Beta Stocks in Biotechnology on NASDAQ

Explore High-Beta Stocks in Biotechnology on NASDAQ. Compare qualifying stocks using fair value, valuation, financial quality, analyst expectations, and market data.

Achieve Life Sciences Inc (ACHV)
Fair Value-38.0% Downside Overvalued Analyst109.7% Upside Market Cap682.7 M P/E-13.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Alterity Therapeutics Ltd (ATHE)
Fair Value2.2% Upside Fair Analyst170.7% Upside Market Cap82.238 M P/E-8.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Altimmune Inc (ALT)
Fair Value-19.9% Downside Overvalued Analyst468.4% Upside Market Cap599 M P/E-6.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Arrowhead Pharmaceuticals Inc (ARWR)
Fair Value-15.3% Downside Fair Analyst25.7% Upside Market Cap12.381 B P/E-38.6x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Coherus BioSciences Inc (CHRS)
Fair Value-1.7% Downside Fair Analyst475.9% Upside Market Cap196.2 M P/E-1.3x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Ironwood Pharmaceuticals Inc (IRWD)
Fair Value49.0% Upside Undervalued Analyst47.3% Upside Market Cap713.8 M P/E5.4x Yield0.0% HealthGreat
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Kazia Therapeutics Ltd ADR (KZIA)
Fair Value-29.2% Downside Overvalued Analyst92.7% Upside Market Cap158.7 M P/E-10.2x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
MannKind Corp (MNKD)
Fair Value16.7% Upside Fair Analyst99.0% Upside Market Cap1.322 B P/E-30.0x Yield0.0% HealthFair
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks Small-Cap Stocks
Myriad Genetics Inc (MYGN)
Fair Value51.4% Upside Bargain Analyst65.7% Upside Market Cap311.8 M P/E-2.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum Small-Cap Stocks
Novavax Inc (NVAX)
Fair Value-9.6% Downside Fair Analyst78.9% Upside Market Cap1.311 B P/E-5.2x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Oncolytics Biotech Inc (ONCY)
Fair Value4.0% Upside Fair Analyst564.9% Upside Market Cap95.782 M P/E-2.7x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Rigel Pharmaceuticals Inc (RIGL)
Fair Value13.7% Upside Fair Analyst37.3% Upside Market Cap750.4 M P/E2.3x Yield0.0% HealthExcellent
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
Agios Pharm (AGIO)
Fair Value26.8% Upside Undervalued Analyst38.8% Upside Market Cap1.927 B P/E-4.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Aldeyra The (ALDX)
Analyst334.2% Upside Market Cap93.498 M P/E-4.0x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Anavex Life Sciences Corp (AVXL)
Fair Value10.6% Upside Fair Analyst494.4% Upside Market Cap309.5 M P/E-9.1x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Arcturus Therapeutics Holdings Inc (ARCT)
Fair Value4.5% Upside Fair Analyst166.5% Upside Market Cap210.6 M P/E-2.2x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Ardelyx Inc (ARDX)
Fair Value15.6% Upside Fair Analyst224.6% Upside Market Cap996.8 M P/E-18.2x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Benitec Biopharma Ltd ADR (BNTC)
Fair Value-28.1% Downside Overvalued Analyst76.7% Upside Market Cap468.2 M P/E-11.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Cardiff Oncology Inc (CRDF)
Fair Value18.1% Upside Undervalued Analyst434.3% Upside Market Cap67.816 M P/E-1.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Crescent Biopharma Inc (CBIO)
Fair Value-19.9% Downside Overvalued Analyst76.4% Upside Market Cap720.8 M P/E-4.3x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Eledon Pharmaceuticals Inc (ELDN)
Analyst137.4% Upside Market Cap285.2 M P/E-3.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum
Fate Therapeutics Inc (FATE)
Fair Value-12.2% Downside Fair Analyst94.3% Upside Market Cap326.4 M P/E-2.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Heron Therapeuti (HRTX)
Analyst442.0% Upside Market Cap92.898 M P/E-3.0x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Ibio Inc (IBIO)
Fair Value4.7% Upside Fair Analyst287.1% Upside Market Cap70.047 M P/E-2.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Inovio Pharmaceuticals Inc (INO)
Fair Value-13.3% Downside Fair Analyst299.8% Upside Market Cap73.241 M P/E-0.9x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Karyopharm Therapeutics Inc (KPTI)
Fair Value13.7% Upside Fair Analyst228.4% Upside Market Cap48.045 M P/E-0.2x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Minerva Neurosciences Inc (NERV)
Analyst118.4% Upside Market Cap203.9 M P/E-0.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Neurogene Inc (NGNE)
Fair Value-13.8% Downside Fair Analyst125.3% Upside Market Cap711.2 M P/E-7.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Savara Inc (SVRA)
Fair Value0.0% Upside Fair Analyst89.1% Upside Market Cap1.478 B P/E-11.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Travere Therapeutics Inc (TVTX)
Fair Value2.6% Upside Fair Analyst18.3% Upside Market Cap5.78 B P/E-85.7x Yield0.0% HealthGreat
  NASDAQ Featured in Rapid Revenue Growth High-Beta Stocks High-Momentum Stocks High-Beta Momentum
TuHURA Biosciences Inc (HURA)
Fair Value-28.6% Downside Overvalued Analyst246.3% Upside Market Cap135.6 M P/E-4.5x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Ultragenyx (RARE)
Fair Value14.8% Upside Fair Analyst104.5% Upside Market Cap2.547 B P/E-4.4x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Uniqure NV (QURE)
Fair Value-19.9% Downside Overvalued Analyst50.6% Upside Market Cap3.22 B P/E-12.9x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Verastem Inc (VSTM)
Fair Value4.2% Upside Fair Analyst123.0% Upside Market Cap610.4 M P/E-3.0x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Abeona Therapeutics Inc (ABEO)
Fair Value4.3% Upside Fair Analyst175.3% Upside Market Cap412.6 M P/E6.2x Yield0.0% HealthGood
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum Small-Cap Stocks
Adicet Bio Inc (ACET)
Fair Value44.5% Upside Undervalued Analyst309.5% Upside Market Cap83.799 M P/E-0.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Atara Biotherapeutics Inc (ATRA)
Fair Value3.9% Upside Fair Analyst63.5% Upside Market Cap76.136 M P/E-7.7x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Avalo Therapeutics Inc (AVTX)
Fair Value-27.5% Downside Overvalued Analyst134.6% Upside Market Cap982.5 M P/E-9.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum Small-Cap Stocks
Cartesian Therapeutics Inc (RNAC)
Fair Value7.0% Upside Fair Analyst296.5% Upside Market Cap267.8 M P/E-1.7x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Crispr Therapeutics AG (CRSP)
Fair Value-23.8% Downside Overvalued Analyst61.2% Upside Market Cap5.175 B P/E-11.6x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Cue Biopharma (CUE)
Fair Value16.3% Upside Fair Analyst338.5% Upside Market Cap113.9 M P/E-5.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Editas Medicine Inc (EDIT)
Fair Value6.3% Upside Fair Analyst108.3% Upside Market Cap442.3 M P/E-5.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Fennec Pharmaceuticals Inc (FENC)
Fair Value8.7% Upside Fair Analyst44.2% Upside Market Cap402.1 M P/E-46.5x Yield0.0% HealthGreat
  NASDAQ Featured in High-Beta Stocks High-Momentum Stocks High-Beta Momentum High-Growth Small-Cap Stocks Small-Cap Stocks
Forum Markets, Inc (FRMM)
Fair Value50.3% Upside Bargain Analyst51.0% Upside Market Cap79.525 M P/E-0.2x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Immunitybio Inc (IBRX)
Fair Value-10.2% Downside Fair Analyst70.0% Upside Market Cap8.097 B P/E-8.0x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Indaptus Therapeutics Inc (INDP)
Fair Value-25.1% Downside Overvalued Analyst747.5% Upside Market Cap133.6 M P/E-7.1x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
InflaRx N.V. (IFRX)
Fair Value-12.7% Downside Fair Analyst335.9% Upside Market Cap271 M P/E-6.0x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Insight Molecular Diagnostics Inc (IMDX)
Fair Value21.4% Upside Undervalued Analyst71.5% Upside Market Cap156 M P/E-3.3x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Intellia Therapeutics Inc (NTLA)
Fair Value8.0% Upside Fair Analyst97.4% Upside Market Cap1.673 B P/E-4.1x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
OUTLOOK THERAPEUTICS INC (OTLK)
Fair Value-20.8% Downside Overvalued Analyst429.4% Upside Market Cap190.7 M P/E-3.1x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Explore listed stocks on NASDAQ with company information and fair value data.